Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
TCBIO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2026-Revenue
2026-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Earnings Growth
YoY
Current
Estimates
Q2.23
+111%
1.42
vs 0.67
Q3.23
+55%
1.27
vs 0.82
Q4.23
-92%
0.33
vs 4.32
Q1.24
-31%
0.55
vs 0.79
Q2.24
-37%
0.89
vs 1.42
Q3.24
N/A
-1.32
vs 1.27
Q4.24
-100%
NA
vs 0.33
Q1.25
+84%
1.01
vs 0.55
Q2.25
+44%
1.28
vs 0.89
Q3.25
+224%
1.64
vs -1.32
Sales Growth
YoY
Current
Estimates
Q2.23
+67%
447.9M vs 268.6M
Q3.23
+36%
472.6M vs 347.4M
Q4.23
+12%
448.2M vs 400.4M
Q1.24
+9%
458.7M vs 422.6M
Q2.24
+5%
472.5M vs 447.9M
Q3.24
-29%
337.8M vs 472.6M
Q4.24
+10%
491.6M vs 448.2M
Q1.25
+3%
471.7M vs 458.7M
Q2.25
-37%
299.2M vs 472.5M
Q3.25
-5%
322.1M vs 337.8M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.01
Q3.23
+2%
0.02
vs 0.02
Q4.23
+1%
0.01
vs 0.02
Q1.24
+1%
0.01
vs 0.01
Q2.24
+1%
0.01
vs 0.01
Q3.24
-2%
-0.02
vs 0.01
Q4.24
+2%
0.02
vs -0.02
Q1.25
+1%
0.01
vs 0.02
Institutionnal Ownership
QoQ
Q1.24
1
1
vs NA
NA